Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclophosphamide for stem cell mobilization in hematologic malignancies
NCT02139280Phase 2Completed
- Sponsor
- Dartmouth Health
- Start
- Dec 2013
- Primary completion
- Jul 2019
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide in hematologic malignancy, sponsored by Dartmouth Health. Started Dec 2013; status: completed.
02
Drugs
cyclophosphamide
03
Conditions
hematologic malignancy
Beyond the preview
Go deeper on NCT02139280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02139280.